caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1902978141

Gary ChenM.D.

Internal MedicineBrooklyn, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
332
Unique beneficiaries
—
Total services
636
Distinct HCPCS
8
Medicare payment
$46K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — above median (cohort median 552).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
41
By payment type
Food and Beverage$1K
REFERRAL NETWORK

Where Gary Chen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Empire City Laboratories, Inc
Clinical Laboratory · Brooklyn, NY
138743
Lenco Diagnostic Laboratories,inc.
Clinical Laboratory · Brooklyn, NY
42122
Sergio Sokol
Cardiology · Hewlett, NY
3378
MAIMONIDES MEDICAL CENTER2299
MIDWOOD AMBULANCE & OXYGEN SERVICE INC15842
Andy Huang
Hematology · Brooklyn, NY
1345
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1260
Fred Fefer
Cardiology · Valley Stream, NY
1238
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
37,318
Beneficiaries
—
Total drug cost
$4.7M
Distinct drugs
195
Brand share
24.2%
Top prescribed drugs
Atorvastatin Calcium2,043 claims
Diclofenac Epolamine1,845 claims
Icosapent Ethyl1,674 claims
Losartan Potassium1,295 claims
Mometasone Furoate1,258 claims